009300 — Sam-A Pharm Co Balance Sheet
0.000.00%
- KR₩104bn
- KR₩48bn
- KR₩96bn
Annual balance sheet for Sam-A Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 63,913 | 52,984 | 77,372 | 71,437 | 68,997 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17,296 | 19,346 | 26,531 | 32,742 | 28,955 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 93,866 | 82,355 | 116,856 | 117,992 | 113,089 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 43,412 | 40,188 | 37,164 | 40,511 | 42,750 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 182,106 | 189,172 | 203,198 | 231,308 | 248,734 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,468 | 14,594 | 21,558 | 21,145 | 20,508 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 15,819 | 17,147 | 22,580 | 30,838 | 28,758 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 166,287 | 172,024 | 180,618 | 200,470 | 219,976 |
Total Liabilities & Shareholders' Equity | 182,106 | 189,172 | 203,198 | 231,308 | 248,734 |
Total Common Shares Outstanding |